I

iTeos Therapeutics
D

ITOS

8.51000
USD
0.33
(4.03%)
مفتوح الان
حجم التداول
9,960
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
310,538,303
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار

العنوان: iTeos Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.